• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Bromobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Bromobenzenes
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Study of 3-Bromo-α-methylbenzyl alcohol (CAS: 52780-14-0)

The chemical compound 3-Bromo-α-methylbenzyl alcohol (CAS: 52780-14-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its brominated aromatic ring and hydroxyl group, serves as a versatile intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential applications in drug discovery, particularly in the development of novel therapeutic agents targeting inflammatory and oncogenic pathways.

In a groundbreaking study published in the Journal of Medicinal Chemistry, researchers investigated the role of 3-Bromo-α-methylbenzyl alcohol as a precursor in the synthesis of small-molecule inhibitors for protein kinases. The study highlighted its efficacy in modulating kinase activity, which is crucial for treating diseases such as cancer and autoimmune disorders. The compound's unique structural features enable it to interact with specific binding sites, thereby enhancing the selectivity and potency of the resulting inhibitors.

Another significant advancement was reported in a recent issue of Bioorganic & Medicinal Chemistry Letters, where scientists utilized 3-Bromo-α-methylbenzyl alcohol to develop a series of benzyl alcohol derivatives with improved pharmacokinetic properties. These derivatives demonstrated enhanced bioavailability and reduced toxicity, making them promising candidates for further preclinical evaluation. The study also emphasized the compound's role in facilitating the introduction of bromine atoms into complex molecular frameworks, a strategy that has proven valuable in medicinal chemistry.

Furthermore, a collaborative research effort between academic and industrial laboratories has shed light on the compound's potential in agrochemical applications. By leveraging its brominated structure, researchers have developed new pesticidal agents with increased efficacy and environmental safety. This interdisciplinary approach underscores the versatility of 3-Bromo-α-methylbenzyl alcohol beyond traditional pharmaceutical uses.

In conclusion, the recent studies on 3-Bromo-α-methylbenzyl alcohol (CAS: 52780-14-0) highlight its multifaceted role in chemical biology and drug development. Its applications range from kinase inhibition to agrochemical innovation, demonstrating its broad utility in diverse scientific domains. Future research is expected to further explore its mechanistic insights and expand its therapeutic and industrial potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)